Distinct prognostic values of ALDH1 isoenzymes in breast cancer
Distinct prognostic values of ALDH1 isoenzymes in breast cancer
复制标题
DOI:
10.1007/s13277-014-2852-6
复制
发表时间:
2015-01
期刊:
影响因子:
--
通讯作者:
Shaokun Wu;W. Xue;Xiaobo Huang;Xiaoli Yu;M. Luo;Ying Huang;Yimin Liu;Z. Bi;X. Qiu;S. Bai
中科院分区:
文献类型:
--
作者:
Shaokun Wu;W. Xue;Xiaobo Huang;Xiaoli Yu;M. Luo;Ying Huang;Yimin Liu;Z. Bi;X. Qiu;S. Bai
Aldehyde dehydrogenase 1 (ALDH1), also known as aldehyde dehydrogenase 1 family, is composed of six enzymes that are expressed at high levels in stem cells and are involved in the regulation of stem cell function. Increased ALDH1 activity has been found in the stem cell populations of leukemia and some solid tumors including breast cancer (BC). However, which ALDH1’s isoenzymes are contributing to ALDH1 activity has not been determined. In addition, the prognostic value of individual ALDH1 isoenzyme is not clear. In the current study, we investigated the prognostic value of ALDH1 isoenzymes in BC patients through “the Kaplan-Meier plotter” (KM plotter) database, in which updated gene expression data and survival information are from a total of 3455 BC patients.ALDH1A1messenger RNA (mRNA) high expression was found to be correlated to worsen overall survival (OS) for all BC patients.ALDH1A2andALDH1L1mRNA high expressions were found to be correlated to better OS for all BC patients. Both ofALDH1A3andALDH1B1mRNA high expressions were not found to be correlated to OS for all BC patients. These results strongly support that ALDH1A1 was only a biomarker for predicting poor survival of BC patients among ALDH1 isoenzymes. ALDH1A1 might be a major contributor of ALDH1 activity in BC, since onlyALDH1A1mRNA high expression was found to be significantly correlated to worsen OS for all BC patients.